Interdisciplinary, internet-based trans health care (i²TransHealth): study protocol for a randomised controlled trial

• DOI: 10.1136/bmjopen-2020-045980
• Publication Date: 2022-02-01T17:06:23Z
• Authors: Timo O. Nieder; Janis Renner; Antonia Zapf; Susanne Sehner; Amra Hot; Hans-Helmut König; Judith Dams; Thomas Grochtdreis; Peer Briken; Arne Dekker
• Keywords: Internet; Cost-Benefit Analysis; R; 16. Peace & justice; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Medicine; Humans; Sexual Health; Delivery of Health Care; Referral and Consultation; Randomized Controlled Trials as Topic

Living in an area with no or deficient structures for trans health care is disadvantageous people. By providing internet-based programme, i²TransHealth aims at reducing structural disadvantages people living areas lacking specialised care. The e-health intervention consists of video consultations and a 1:1 chat study therapist. Additionally, the network cooperates physicians, who especially offer crisis close to participants' place residence. aim this evaluate (cost-)effectiveness programme compared control (waiting) group. following research questions will be examined sample 163 people: Does 4-month treatment improve patient-reported health-outcomes? Is cost-effective standard from societal payers' perspective? participation support by lead increase trans-related expertise physician network?In randomised controlled trial, outcomes investigated. In group, participants are invited use 4 months. Participants allocated group able start their transition-related after months participation. primary outcome measure defined as reduction psychosomatic symptoms, assessed Brief Symptom Inventory-18, using programme. both groups undergo assessment baseline i²TransHealth.Positive ethical approval was obtained Hamburg Medical Association (PV7131). results disseminated service users families via media, professionals professional training meetings researchers conferences publications.NCT04290286.22 December 2021 (V.1.0).